glp 1 for diabetes type 2 GLP-1RAs Reduce External Eating Behavior with GLP-1 Receptor Agonists as Treatments

Key Takeaways Semaglutides like Ozempic and Wegovy, as well as tirzepatides like Mounjaro and Zepbound, have become popular medications for managing both weight and diabetes

This is not based on Patchie-specific clinical research but on general patterns with metabolic support supplements

The reality: Short-Term Illness Impact : A week of illness with reduced activity and altered eating patterns might cause temporary weight fluctuations, but these are primarily due to: Changes in hydration status Reduced physical activity Altered eating patterns Inflammation and fluid retention Long-Term Progress : Short illnesses dont significantly impact your overall weight trajectory

GLP-1s are now FDA-approved to treat many conditions, including obesity, obstructive sleep apnea, and metabolic-associated steatohepatitis

It also helps with weight loss by reducing appetite, slowing down digestion (gastroparesis), and making you feel fuller longer